Ledger.Open graph →

SEC Form D · filed May 27, 2025

GT Biopharma, Inc

Offering

$6.0M

Sold

$6.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

SAN FRANCISCO, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Michael Breen · SAN FRANCISCO, CAExec Hilary Kramer · SAN FRANCISCO, CADirector Alan Urban · SAN FRANCISCO, CAExec Charles Casamento · SAN FRANCISCO, CADirector Andrew Ritter · SAN FRANCISCO, CADirector Alan Urban · SAN FRANCISCO, CAExec Andrew Ritter · SAN FRANCISCO, CADirector Hilary Kramer · SAN FRANCISCO, CADirector Charles Casamento · SAN FRANCISCO, CADirector Michael Breen · SAN FRANCISCO, CAExec Walt Krumbholz · Seattle, WAExec Maggie Weiland · Seattle, WAExec Lisa Dow · Seattle, WADirector Turner Waskom · Seattle, WADirector Carl Seip · Seattle, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗